Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
批准号:
10706729
负责人:
Adolfo Garcia-Sastre
金额:
$12.01万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-30 至 2025-08-31
关键词:
2019-nCoVACE2AdultAdvocateAgeAggressive courseAntibodiesAntibody ResponseBioinformaticsBiologyBiometryBudgetsCOVID-19COVID-19 mortalityCOVID-19 patientCOVID-19 susceptibilityCOVID-19 vaccinationCOVID-19 vaccineCancer PatientCardiopulmonaryCellsCharacteristicsClinicalClinical SciencesClinical TrialsComplementContractsControl GroupsCytoprotectionData ScienceData Science CoreDemographic FactorsDevelopmentDiseaseDoctor of PhilosophyEpithelial CellsEthnic OriginFatality rateGenderHistologyImmuneImmune responseIncidenceIndividualInfectionInformaticsKineticsKnowledgeLongevityLungLung NeoplasmsMalignant NeoplasmsMalignant neoplasm of lungMediatingMorbidity - disease rateNormal tissue morphologyPatient RecruitmentsPatientsPersonsPlayPopulation ControlPredispositionRaceRecording of previous eventsResearchRisk FactorsRoleSARS-CoV-2 antibodySARS-CoV-2 infectionScienceSerologySeroprevalencesSmokingSmoking HistoryTobaccoVaccinationVaccinesViralViral Load resultVirusVirus DiseasesVirus Replicationbasecancer therapycigarette smokingcomorbiditydata disseminationhuman subjectinter-individual variationlung cancer cellmembermultidisciplinaryneoplastic cellneutralizing antibodypatient populationprogramsprotective efficacypublic databaseresponsesample collectiontumorvaccine trial
中文摘要
作为我们现有U54的补充,我们建议将西奈山作为一个协调站点,汇总和分析由SeroNet支持的多项肺癌研究的人口统计学、临床和分子数据。这些来自全国知名机构的研究一直在研究肺癌和SARS-CoV-2的交叉关系,以探索这两种联合疾病对患者健康的影响,调查导致不良结果的潜在生物学因素,并了解肺癌疾病和/或治疗对SARS-CoV-2疫苗诱导的免疫反应的影响。为了实现这一目标,我们将利用约瑟夫·芬克尔斯坦(Joseph Finkelstein)领导的西奈山生物信息学小组的丰富专业知识和经验,以及范德比尔特大学统计学系合作伙伴的数据分析能力。
英文摘要
As a supplement to our existing U54, we propose that Mount Sinai serve as a coordinating site for aggregating and analyzing demographic, clinical and molecular data from multiple lung cancer studies supported by SeroNet. These studies, from prominent institutions across the country, have been investigating the intersection of lung cancer and SARS-CoV-2 to explore the impact of the combined diseases on patient health, investigate the underlying biology that leads to poor outcomes and understand the effects of lung cancer disease and/or treatments on SARS-CoV-2 vaccination-induced immune responses. To accomplish this goal, we will leverage the considerable expertise and experience of the Mount Sinai Bio-informatics group, led by Joseph Finkelstein, and the data analysis capabilities of our partners at the Vanderbilt Department of Statistics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A deep longitudinal analysis of next generation influenza vaccines in older adults
-
批准号:10544172
-
项目类别:
-
资助金额:$219.59万
-
财政年份:2022
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Immune phenotyping of responses to influenza virus vaccination and infection
-
批准号:10595642
-
项目类别:
-
资助金额:$21.69万
-
财政年份:2022
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
In vivo virology core
-
批准号:10512625
-
项目类别:
-
资助金额:$376.07万
-
财政年份:2022
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Admin-Core-001
-
批准号:10710092
-
项目类别:
-
资助金额:$12.01万
-
财政年份:2022
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
A deep longitudinal analysis of next generation influenza vaccines in older adults
-
批准号:10342393
-
项目类别:
-
资助金额:$162.26万
-
财政年份:2022
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Immune phenotyping of responses to influenza virus vaccination and infection
-
批准号:10435237
-
项目类别:
-
资助金额:$28.32万
-
财政年份:2022
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Development of CoV inhibitors against non-enzymatic targets
-
批准号:10514327
-
项目类别:
-
资助金额:$512.2万
-
财政年份:2022
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
-
批准号:10222305
-
项目类别:
-
资助金额:$396.84万
-
财政年份:2020
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
-
批准号:10688370
-
项目类别:
-
资助金额:$204.42万
-
财政年份:2020
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Core G - IOF Management Core
-
批准号:10153663
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2020
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
-
批准号:10855044
-
项目类别:
-
资助金额:$327.19万
-
财政年份:2020
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Project 2: Susceptibility of Lung Cancer Cells to SARS- CoV-2 Infection and Antibody-Mediated Neutralization
-
批准号:10688382
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2020
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Project 2: Susceptibility of Lung Cancer Cells to SARS- CoV-2 Infection and Antibody-Mediated Neutralization
-
批准号:10222310
-
项目类别:
-
资助金额:$87.85万
-
财政年份:2020
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza viruses
-
批准号:10066306
-
项目类别:
-
资助金额:$115.35万
-
财政年份:2019
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza viruses
-
批准号:10534661
-
项目类别:
-
资助金额:$112.69万
-
财政年份:2019
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza viruses
-
批准号:10318120
-
项目类别:
-
资助金额:$112.69万
-
财政年份:2019
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza viruses
-
批准号:9625439
-
项目类别:
-
资助金额:$145.01万
-
财政年份:2019
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Core A - Administrative Core
-
批准号:10080701
-
项目类别:
-
资助金额:$35.81万
-
财政年份:2018
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
SARS-CoV adaptations through a Systems Biology Lens (SYBIL)
-
批准号:10551578
-
项目类别:
-
资助金额:$265.15万
-
财政年份:2018
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
Core C - Modeling Core
-
批准号:10551582
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2018
-
负责人:Adolfo Garcia-Sastre
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
AURKA介导ACE2磷酸化修饰调控内皮细胞衰老在低氧性肺动脉高压中的作用及机制研究
-
批准号:82570085
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:沈慧
-
依托单位:
牛蒡叶倍半萜成分群激活ACE2/Ang1-7/MasR轴调控血管内皮—周细胞互作促缺血性脑卒中血管正常化机制研究
-
批准号:82404910
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:郝单丽
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
ACE2通过AMPK/SIRT3调控线粒体代谢改善盐敏感性高血压肾脏纤维化的机制
-
批准号:82460087
-
项目类别:地区科学基金项目
-
资助金额:33.00万元
-
批准年份:2024
-
负责人:赵宇
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位: